Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Gliadel approved for new indication in Europe

Sep. 17, 2004

Pivotal trial of NovaCaps given green light by EMEA

Sep. 16, 2004

SPA for phase III study of glufosfamide for metastatic pancreatic cancer

Sep. 15, 2004

Iressa studied in new head-to-head trial for NSCLC

Sep. 15, 2004

Oncomer converts solitary tumor into bloodless mass

Sep. 15, 2004

AustCancer acquires North American rights to RP-101

Sep. 15, 2004

New phase IIIb study of Tarceva in advanced NSCLC

Sep. 15, 2004

Novel HDAC inhibitors prepared and tested at Oxford GlycoSciences

Sep. 15, 2004

Bonefos accepted for priority review

Sep. 14, 2004

Assessment of survival of advanced NSCLC patients treated with gefitinib

Sep. 13, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...